Cited by 39Nanoplatforms for cancer theranosticsLuminescence and Fluorescent MaterialsOptical Imaging and Spectroscopy Techniques

New Xanthene Dyes with NIR‐II Emission Beyond 1200 nm for Efficient Tumor Angiography and Photothermal Therapy

Zhang, Chuangli, Wu, Jiasheng, Liu, Weimin, Zhang, Wenjun, Lee, Chun‐Sing, Wang, Pengfei·2022·Small

Abstract

Fluorescence (FL) bioimaging in the second near‐infrared window (NIR‐II, 1000–1700 nm) provides improved imaging quality and high resolution for diagnosis of deep‐seated tumors. However, integrating FL bioimaging and photothermal therapy (PTT) in a single photoactive molecule exhibits a great challenge because a dramatic increase of PTT in the NIR‐II window benefitting from the nonradiative decay will sacrifice the fluorescence brightness that is unfavorable for FL bioimaging. Therefore, balancing the radiative decay and nonradiative decay is an effective and rational design strategy. Herein, four NIR‐II xanthene dyes (CL1–CL4) are synthesized with maximal emission beyond 1200 nm under 1064 nm excitation. CL4 exhibits the largest fluorescence quantum yield and a significant fluorescence enhancement after complexation with fetal bovine serum (FBS). As‐prepared CL4/FBS has a maximal emission of 1235 nm and a high photothermal conversion efficiency of 36% under 1064 nm excitation. Bright and refined tumor vessels with a fine resolution of 0.23 mm can be clearly distinguished by CL4/FBS. In vivo studies show that a balanced utilization of fluorescence and photothermy in the NIR‐II window is successfully achieved with superior biocompatibility. This efficient strategy provides promising avenue for precise theranostics of deep tumors.

Integrity signals

Registry

Crossref · 10.1002/smll.202202078

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The CL4/FBS system demonstrated capability for NIR-II fluorescence imaging of tumor vasculature, achieving a resolution of 0.23 mm.

    “Furthermore, this system demonstrated exceptional capability for NIR-II fluorescence imaging of tumor vasculature, achieving a resolution of 0.23 mm.”
  • Following intravenous injection, the CL4/FBS complex attained peak tumor accumulation at 32 h, demonstrating significantly superior tumor enrichment efficacy relative to free CL4.

    “Following intravenous injection, the complex attained peak tumor accumulation at 32 h, demonstrating significantly superior tumor enrichment efficacy relative to free CL4.”
  • Compared to CL4 alone, the CL4/FBS complex showed significantly reduced cytotoxicity, indicating improved biocompatibility.

    “Compared to CL4 alone, the complex showed significantly reduced cytotoxicity, indicating improved biocompatibility.”
  • Upon irradiation with a 1064 nm laser, the CL4/FBS complex elevated the tumor temperature to 53 °C within 10 min, effectively suppressing 4T1 tumor growth through PTT.

    “Upon irradiation with 1064 nm laser, CL4/FBS complex elevated the tumor temperature to 53 °C within 10 min, effectively suppressing 4T1 tumor growth through PTT.”
  • In aqueous solution, the CL4/FBS complex displayed a blue-shifted maximum emission at 1235 nm, alongside a 3.6-fold fluorescence intensity enhancement and a PCE of 36%.

    “In aqueous solution, the CL4/FBS complex displayed a blue-shifted maximum emission at 1235 nm, alongside a 3.6-fold fluorescence intensity enhancement and a PCE of 36%.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhang, C., Wu, J., Liu, W., Zhang, W., Lee, C., & Wang, P.
Affiliations
  • Chinese Academy of Sciences (CN)
  • City University of Hong Kong (HK)
Corresponding author
  • Wu, Jiasheng
  • Wang, Pengfei
Venue
Small
Publisher
Wiley
Published
2022-06-22
Volume
18
Issue
29
Pages
e2202078-e2202078
ISSN
  • 1613-6810 (ISSN-L)
  • 1613-6829
OpenAlex
W4283318757
Cited by
39
References
58
Citations by year
2026: 3 · 2025: 13 · 2024: 10 · 2023: 10 · 2022: 3
FWCI
2.61
Type
journal article
Language
en
Open access
closed
Locations
  • Small (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (21873110, 61720106014)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Materials Science › Materials Chemistry › Luminescence and Fluorescent Materials
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Optical Imaging and Spectroscopy Techniques
Keywords
xanthene dyes, NIR-II fluorescence, second near-infrared window, photothermal therapy, tumor angiography, fluorescence enhancement, fluorescence quantum yield, photothermal conversion efficiency, theranostics
MeSH terms
Theranostic Nanomedicine, Photothermal Therapy, Angiography, Coloring Agents, Fluorescent Dyes, Humans, Neoplasms, Phototherapy, Xanthenes, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review